Norfloxacin and salmonella excretion in acute gastroenteritis - A 6-month follow-up study

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 2, 1996, Pages 177-180

  Pitkäjärvi, Timo ^a   Kujanne, Eija ^a   Sillantaka, Irmeli ^a   Lumio, Jukka ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NORFLOXACIN;

ACUTE GASTROENTERITIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXCRETION; FECES CULTURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; SALMONELLA; SALMONELLOSIS;

EID: 0029938752     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609049071     Document Type: Article

References (17)

1. Neill MA, Opal SM, Heelan J, Giusti R, Cassidy JE, White R, Mayer KH. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis; experience during an outbreak in health care workers. Ann Intern Med 114: 195-199, 1991.
2. Shungu DL, Weinberg E, Gadesbusch HH. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. Antimicrob Agents Chemother 23: 86-90, 1983.
3. Holmes B, Brodgen RN, Richards DM. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 30: 482-513, 1985.
4. Edlund C, Bergan T, Josefsson K. Solberg R, Nord CE. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple dose pharmacokinetics. Scand J Infect Dis 19: 113-121, 1987.
5. Rogerie F, Ott D, Vandepitte J, Verbist L, Lemmens P, Habiyaremye I. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type I in adults. Antimicrob Agents Chemother 29: 883-886, 1986.
6. DuPont HL, Corrado ML, Sabbaj J. Use of norfloxacin in the treatment of acute diarrheal disease. Am J Med 82 (Suppl. 6B): 79-83, 1987.
7. Lolekha S, Patanachareon S, Thanangkul B, Vibulbandhitkit S. Norfloxacin versus cotrimoxazole in the treatment of acute bacterial diarrhoea: a placebo controlled study. Scand J Infect Dis 20 (Suppl 56): 35-45, 1988.
8. Wiström J, Norrby R, Burman LG, Lundholm R, Jellheden B, Englund G. Norfloxacin versus placebo for prophylaxis against traveller's diarrhoea. J Antimicrob Chemother 20: 563-574, 1987.
9. Pichler HET, Dirdl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhoea. Am J Med 82: 329-332, 1987.
10. DuPont HL, Ericsson CD, Mathewson JJ, DuPont MW. Five versus three days of ofloxacin therapy for traveller's diarrhoea: a placebo-controlled study. Antimicrob Agents Chemother 36: 87-91, 1992.
11. Petrucelli BP, Murphy GS, Sanchez JL, Walz S, DeFraites R, Gelnett S, Haberberger RL, Echeverria P, Taylor DN. Treatment of traveller's diarrhoea with ciprofloxacin and loperamide. J Infect Dis 165: 557-560, 1992.
12. Mattila L, Peltola H, Siitonen A, Kyrönseppä H, Simula I, Kataja M. Short-term treatment of traveler's diarrhoea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 17: 779-782, 1993.
13. Asperilla MO, Smego RA, Jr, Scott LK. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis 12 (5): 873-889, 1990.
14. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, Nelson JA, Mayer KW, Landau GW, Levin S. Empiric antimicrobial therapy of domestically acquired acute diarrhoea in urban adults. Arch Intern Med 150: 541-546, 1990.
15. Aserkov B, Bennett JV. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med 281: 646-640, 1969.
16. Wiström J, Jetborn M, Ekwall E, Norlin K, Söderquist B, Strömberg A, Lundholm R, Hogevik H, Lagergren L, Englund G, Norrby R and the Swedish Study Group. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Ann Intern Med 117: 202-208, 1992.
17. Carlstedt G, Dahl P, Niklasson PM, Gullberg K, Banck G, Kahlmeter G. Norfloxacin treatment of salmonellosis does not shorten the carrier state. Scand J Infect Dis 22: 553-556, 1990.